HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1397149Generated: October 25, 2026
Lithium Hexamethyldisilazide → 1-(4'-(Cyclopropylmethyl)-2-(4-(methylsulfonyl)phenylamino)-4,5'-bipyrimidin-2'-ylamino)-2-methylpropan-2-ol
https://huagongshe.com/reaction/1397149
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Lithium Hexamethyldisilazide | HCID 2733832 | — |
| Reactant | 4-Sulfonylaniline | HCID 20432622 | — |
| Reactant | 1-(4'-(Cyclopropylmethyl)-2-(methylsulfinyl)-4,5'-bipyrimidin-2'-ylamino)-2-methylpropan-2-ol | HCID 67983640 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 1-(4'-(Cyclopropylmethyl)-2-(4-(methylsulfonyl)phenylamino)-4,5'-bipyrimidin-2'-ylamino)-2-methylpropan-2-ol | HCID 67983994 | 17% |
Reaction Steps
To a solution of 4-sulfonylaniline (71.1 mg, 0.415 mmol) in THF (277 μl) cooled to −78° C. under nitrogen, LiHMDS (69.4 mg, 0.415 mmol) was added dropwise. The reaction mixture was warmed up to rt, then was stirred for 30 min. To the reaction mixture cooled back to −78° C., 1-(4′-(cyclopropylmethyl)-2-(methylsulfinyl)-4,5′-bipyrimidin-2′-ylamino)-2-methylpropan-2-ol (5-3) (50 mg, 0.138 mmol) was added, and the reaction mixture was warmed up to rt, then was stirred for additional 1 h. According to LC/MS, the reaction was complete. The crude product was purified by reverse-phase HPLC [30-100% organic phase over 15 min] followed by Biotage silica gel chromatography [10 g SNAP column, 100% DCM to 12% MeOH/DCM] to obtain the desired product (11 mg, 17%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08901147B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-ed2704d1bf124de0a3730843065b2920 |
|---|
| Source note | uspto-grants-2014_12 |
|---|